About the journal
Medicine in Drug Discovery is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,010 USD. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2590-0986
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,010 USD
- Articles in DOAJ
- 243
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/medicine-in-drug-discovery
Index listings
- DOAJ · 2019-12-23
- Indexing
- DOAJ
- APC
- 3,010 USD
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
243
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
244
Last recorded publication year
2026
h-index
45
i10-index
114
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2019-12-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 44%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101765689
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
Show all subjects (50)
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- Circadian rhythm and melatonin
- Circadian rhythm and melatonin
- Sleep and Wakefulness Research
- Immunotherapy and Immune Responses
- Sleep and Wakefulness Research
- Sleep and related disorders
- Sleep and related disorders
- Immunotherapy and Immune Responses
- Synthesis and biological activity
- Adenosine and Purinergic Signaling
- Receptor Mechanisms and Signaling
- Synthesis and biological activity
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
- Monoclonal and Polyclonal Antibodies Research
- Drug Transport and Resistance Mechanisms
- Vitamin C and Antioxidants Research
- Advanced Drug Delivery Systems
- Adenosine and Purinergic Signaling
- Chemical Synthesis and Analysis
- Receptor Mechanisms and Signaling
- Chemical Synthesis and Analysis
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
- Drug Transport and Resistance Mechanisms
- Monoclonal and Polyclonal Antibodies Research
- Vitamin C and Antioxidants Research
- Advanced Drug Delivery Systems
- Neuropeptides and Animal Physiology
- Peptidase Inhibition and Analysis
- Venomous Animal Envenomation and Studies
- Vitamin D Research Studies
- Neuropeptides and Animal Physiology
- Peptidase Inhibition and Analysis
- Antimicrobial Peptides and Activities
- Venomous Animal Envenomation and Studies
- Antimicrobial Peptides and Activities
- Vitamin D Research Studies
Keywords (DOAJ)
- drug discovery
- drug delivery
- medicinal chemistry
- drug development and commercialization
- translational science
- cell therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ